(MedPage Today) -- DENVER -- An estimated one in 12 U.S. adolescents with early syphilis also have HIV in a national surveillance sample, but the burden of co-occurring syphilis and...

(MedPage Today) -- When I was 16 -- one of the youngest students in my graduating class at Haverford High School -- I set my sights on Haverford College. It...

(MedPage Today) -- As "The Pitt" continues its second season, MedPage Today is examining the drama through the perspective of an emergency physician. Practicing emergency room (ER) doctor Jeremy Faust,...

PHILADELPHIA -- Oral remibrutinib (Rhapsido) increased peanut tolerance in adults with proven allergy to it, with benefits in as little as 1 week, a phase II trial showed. After 4...

Share on PinterestCriminal Minds and Archer star Aisha Tyler is opening up about taking preventive health more seriously following her father’s stroke, and the healthy habits she’s adopted to boost...

(MedPage Today) -- SAN FRANCISCO -- The adjuvant combination of pembrolizumab (Keytruda) and belzutifan (Welireg) significantly improved disease-free survival (DFS) in patients with clear cell renal cell carcinoma (ccRCC) after...

The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up can...

(MedPage Today) -- PHILADELPHIA -- For multi-allergen oral immunotherapy (mOIT) patients, adding dupilumab (Dupixent) after omalizumab (Xolair) showed promise for cutting the gastrointestinal adverse events (AE) of ongoing mOIT, although...

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president...

(MedPage Today) -- I didn't think about killing myself today. The realization caused me to look up from my epic fantasy book, "Way of Kings." Seated on my bed as...

(MedPage Today) -- Online influencers claim the secret to low-calorie rice, pasta, and potatoes may be as simple as chilling out. Are they right? Not quite. But a small yet...

(MedPage Today) -- SAN FRANCISCO -- Dual antiangiogenic therapy for previously treated kidney cancer significantly improved progression-free survival (PFS) versus a single drug, a large randomized trial showed. Median PFS...

(MedPage Today) -- DENVER -- The two-drug combination of doravirine and islatravir was as efficacious as the three-drug regimen of bictegravir, emtricitabine, and tenofovir alafenamide (Biktarvy) as initial therapy in...

Share on PinterestCardiovascular and metabolic health are intrinsically linked, with diabetes and kidney disease as major risk factors for heart disease. PER Images/StocksyA new report suggests that millions of U.S....

Twenty-five women have received compensation following gynaecological surgery. Source link : https://www.bbc.com/news/videos/c8754y8yzpyo?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-02-27 23:00:00 Copyright for syndicated content belongs to the linked Source.

Kerry Watson takes more than 100 tablets a week to deal with the pain caused by a vaginal mesh implant. Source link : https://www.bbc.com/news/articles/crrxe7qjejjo?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-02-27...

(MedPage Today) -- SAN FRANCISCO -- The first-line combination of olaparib (Lynparza) plus abiraterone (Zytiga) led to a significant overall survival (OS) advantage for patients with metastatic castration-resistant prostate cancer...

(MedPage Today) -- More parents refused to let newborn children have vitamin K shots, which may lead to vitamin K deficiency bleeding and future brain complications, a systematic literature review...

(MedPage Today) -- Lawmakers have been silent for too long about insurers' abuses, but all that is about to change, said Rep. Greg Murphy, MD, (R-N.C.) during the American Medical...

(MedPage Today) -- DENVER -- A daily, single-tablet combination of bictegravir and lenacapavir (Yeztugo) was noninferior to complex multi-tablet regimens at maintaining virological suppression in people with HIV who can't...